Inspec

Inspec Debt/Market Cap

The Debt to Market Capitalization Ratio of Inspec (6656.T) as of Oct 23, 2026 is 91.17 %. In the previous year, Debt to Market Capitalization Ratio was 68.16 % — a change of 33.76% (higher).

Debt/Market Cap

91.17 %

YoY

33.76%

Last updated:

Debt to Market Capitalization Ratio of Inspec is 2026 91.17 % . Debt to Market Capitalization Ratio of Inspec was 2025 68.16 % . It decreases by 33.76% higher compared to the previous year.

The Inspec Debt/Market Cap history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/Market Cap
Date
Debt/Market Cap
Jan 1, 2019
35.02 JPY
Jan 1, 2020
56.13 JPY
Jan 1, 2021
55.07 JPY
Jan 1, 2022
71.98 JPY
Jan 1, 2023
89.68 JPY
Jan 1, 2024
95.20 JPY
Jan 1, 2025
68.16 JPY
Jan 1, 2026
91.17 JPY
The Inspec Debt/Market Cap history
YEARDebt/Market CapYoY
91.17 %+33.76%
68.16 %-28.40%
95.20 %+6.16%
89.68 %+24.60%
71.98 %+30.69%
55.07 %-1.89%
56.13 %+60.27%
35.02 %-37.40%
55.95 %+59.12%
35.16 %-8.72%
38.52 %-10.05%
42.82 %+96.51%
21.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

Debt to Market Capitalization Ratio of Inspec is 91.17 % in 2026.

Debt to Market Capitalization Ratio of Inspec changed from 68.16 % to 91.17 %, representing a 33.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt to Market Capitalization Ratio Inspec since 2006 – with annual values, charts, and detailed analysis.

Debt/Market Cap compares total debt to the market value of equity. It provides a market-based view of financial leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt to Market Capitalization Ratio's Inspec with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Inspec

All Key Metrics — Inspec